Robert L. Bevins, Ph.D. - Publications

Affiliations: 
2005 University of Kentucky, Lexington, KY 
Area:
Toxicology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Song L, Bevins R, Anderson BD. Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecins. Journal of Medicinal Chemistry. 49: 4344-55. PMID 16821794 DOI: 10.1021/Jm060016L  0.346
2006 Tangirala RS, Antony S, Agama K, Pommier Y, Anderson BD, Bevins R, Curran DP. Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin. Bioorganic & Medicinal Chemistry. 14: 6202-12. PMID 16793274 DOI: 10.1016/J.Bmc.2006.05.073  0.392
2005 Bevins RL, Zimmer SG. It's about time: scheduling alters effect of histone deacetylase inhibitors on camptothecin-treated cells. Cancer Research. 65: 6957-66. PMID 16061681 DOI: 10.1158/0008-5472.Can-05-0836  0.462
2002 Du W, Curran DP, Bevins RL, Zimmer SG, Zhang J, Burke TG. Synthesis and evaluation of a novel E-ring modified alpha-hydroxy keto ether analogue of camptothecin. Bioorganic & Medicinal Chemistry. 10: 103-10. PMID 11738612 DOI: 10.1016/S0968-0896(01)00252-8  0.458
2001 Bom D, Curran DP, Zhang J, Zimmer SG, Bevins R, Kruszewski S, Howe JN, Bingcang A, Latus LJ, Burke TG. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 74: 325-33. PMID 11489514 DOI: 10.1016/S0168-3659(01)00343-1  0.456
Show low-probability matches.